Epitalon

Epithalon · AEDG · F-tier (Dr. Alex Tatem) · Preclinical evidence

Marketed as a telomere-lengthening “fountain of youth”. The evidence is benchtop cell work plus low-quality Russian reports.

Dr. Tatem’s take

F-tier: going from benchtop cell studies to a whole-body injection “is a monumental leap”, and it’s “the first compound that you’re going to see faked or counterfeited.” On Diary of a CEO: “I’m very skeptical.”

In Dr. Tatem’s tier list

• The first compound on his list built specifically for longevity: it’s supposed to lengthen telomeres.
• His explainer: every time a cell copies its DNA, the copying machinery can’t reach the very end, so chromosomes lose a little each division. Telomeres are the disposable caps that absorb that loss and shorten with age; the enzyme telomerase can rebuild them. Epitalon is claimed to stimulate telomerase.
• That’s been shown in a few cell lines, but extrapolating to an injection that goes throughout the whole body “is a monumental leap.” There’s no way to measure the effect in a living person, and nobody has lived long enough to prove a benefit.
• “This is the first compound that you’re going to see faked or counterfeited or just being salt water.”
• Verdict: the first F tier — “Save your money and I don’t know, buy more creatine.”

History & background

Epitalon (Ala-Glu-Asp-Gly) was synthesized in the late 1980s–1990s by Vladimir Khavinson’s group at the St. Petersburg Institute of Bioregulation and Gerontology, as a synthetic version of “epithalamin,” a crude extract of bovine pineal gland.

Most human data are small Russian studies from that group without modern randomized design. Despite that, FDA advisers voted 7–4–1 in July 2026 to recommend it for compounding (insomnia); the vote is non-binding.

Benefits

• Telomerase activity in cell lines.
• Melatonin effects reported in older studies.

Risks

• Unknown in humans.
• Theoretical: activating telomerase could help cancer cells.
• High counterfeit risk.

Dosing protocols (informational, labeled by evidence)

• Community (bro science): Common community cycle — 5–10 mg, SubQ (evening), Daily, 10–20 consecutive days, repeated every 4–6 months

Status: Not approved. FDA advisers voted 7–4–1 in July 2026 to allow compounding (insomnia). Rulemaking is pending.

Grade and commentary: Dr. Alex Tatem. Watch: The Truth About Popular Peptides (What Works, What’s Overhyped) | Peptide Tier List pt.1, The Fountain of Youth Peptide? The Truth About Epitalon. Subscribe: @DrAlexTatem.